The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Platinum-based drugs for cancer therapy and anti-tumor strategies
Open accessAbstract
Platinum-based drugs cisplatin, carboplatin, and oxaliplatin are widely used for chemotherapeutic eradication of cancer. However, the side effects of platinum drugs, such as lack of selectivity, high systemic toxicity, and drug resistance, seriously limit their clinical application. With advancements in nanotechnology and chemical synthesis, Pt-based anti-cancer drugs have made great progress in cancer therapy in recent years. Many strategies relied on the anti-cancer mechanism similar to cisplatin and achieved some success by modifying existing platinum drugs. Pt-based nanodrugs, such as platinum nanoclusters, have novel anti-cancer mechanisms and great potential in tumor-targeted therapy and have shown promising results in clinical application. In this review, we systematically explored the development of first-line platinum chemotherapy drugs in the clinic and their anti-cancer mechanisms. We also summarize the progress of Pt-based anti-cancer drug application in cancer therapy, emphasizing their modification to enhance the anti-tumor effect. Finally, we address challenges faced by platinum chemotherapy drugs, especially Pt nanocluster-based nanodrugs, in cancer treatment. The new platinum drugs and their targeted modifications undoubtedly provide a promising prospect for improving the current anti-cancer treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cisplatin in cancer therapy: Molecular mechanisms of action
Dasari, S., & Bernard Tchounwou, P. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.025 · Cited by 5,537
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
Johnstone, T. C., Suntharalingam, K., & Lippard, S. J. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00597 · Cited by 2,485
Current Status of Platinum-Based Antitumor Drugs
Wong, E., & Giandomenico, C. M. (1999) · Chemical Reviews · doi:10.1021/cr980420v · Cited by 1,800
Florea, A.-M., & Büsselberg, D. (2011) · Cancers · doi:10.3390/cancers3011351 · Cited by 1,759
Diverse Applications of Nanomedicine
Pelaz, B., Alexiou, C., Alvarez-Puebla, R. A., Alves, F., Andrews, A. M., Ashraf, S., Balogh, L. P., Ballerini, L., Bestetti, A., Brendel, C., et al. (2017) · ACS Nano · doi:10.1021/acsnano.6b06040 · Cited by 1,350
Metallodrugs in Medicinal Inorganic Chemistry
Mjos, K. D., & Orvig, C. (2014) · Chemical Reviews · doi:10.1021/cr400460s · Cited by 1,289
Gold Nanomaterials at Work in Biomedicine
Yang, X., Yang, M., Pang, B., Vara, M., & Xia, Y. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00193 · Cited by 1,162
The rediscovery of platinum-based cancer therapy
Rottenberg, S., Disler, C., & Perego, P. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00308-y · Cited by 972
Recent progresses in small-molecule enzymatic fluorescent probes for cancer imaging
Liu, H.-W., Chen, L., Xu, C., Li, Z., Zhang, H., Zhang, X.-B., & Tan, W. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00862g · Cited by 948
Self-citationPlatinum-based drugs: past, present and future
Dilruba, S., & Kalayda, G. V. (2016) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-016-2976-z · Cited by 906
Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin
Brown, S. D., Nativo, P., Smith, J.-A., Stirling, D., Edwards, P. R., Venugopal, B., Flint, D. J., Plumb, J. A., Graham, D., & Wheate, N. J. (2010) · Journal of the American Chemical Society · doi:10.1021/ja908117a · Cited by 865
ER stress: Autophagy induction, inhibition and selection
Rashid, H.-O., Yadav, R. K., Kim, H.-R., & Chae, H.-J. (2015) · Autophagy · doi:10.1080/15548627.2015.1091141 · Cited by 795
Yang, R., Xu, J., Xu, L., Sun, X., Chen, Q., Zhao, Y., Peng, R., & Liu, Z. (2018) · ACS Nano · doi:10.1021/acsnano.7b09041 · Cited by 698
Oxaliplatin: A review of preclinical and clinical studies
Raymond, E., Chaney, S. G., Taamma, A., & Cvitkovic, E. (1998) · Annals of Oncology · doi:10.1023/a:1008213732429 · Cited by 643
Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
Kenny, R. G., & Marmion, C. J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00271 · Cited by 636
The Discovery and Development of Cisplatin
Alderden, R. A., Hall, M. D., & Hambley, T. W. (2006) · Journal of Chemical Education · doi:10.1021/ed083p728 · Cited by 532
Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications
Spicer, C. D., Jumeaux, C., Gupta, B., & Stevens, M. M. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00877e · Cited by 497
Yuan, Y., Kwok, R. T. K., Tang, B. Z., & Liu, B. (2014) · Journal of the American Chemical Society · doi:10.1021/ja411811w · Cited by 474
Targeting the Thioredoxin System for Cancer Therapy
Zhang, J., Li, X., Han, X., Liu, R., & Fang, J. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.06.001 · Cited by 460
Platinum nanoparticles in nanobiomedicine
Pedone, D., Moglianetti, M., De Luca, E., Bardi, G., & Pompa, P. P. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00152e · Cited by 454
Advances in Toxicological Research of the Anticancer Drug Cisplatin
Qi, L., Luo, Q., Zhang, Y., Jia, F., Zhao, Y., & Wang, F. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00204 · Cited by 440
Precise nanomedicine for intelligent therapy of cancer
Chen, H., Gu, Z., An, H., Chen, C., Chen, J., Cui, R., Chen, S., Chen, W., Chen, X., Chen, X., et al. (2018) · Science China Chemistry · doi:10.1007/s11426-018-9397-5 · Cited by 409
FePt@CoS2 Yolk−Shell Nanocrystals as a Potent Agent to Kill HeLa Cells
Gao, J., Liang, G., Zhang, B., Kuang, Y., Zhang, X., & Xu, B. (2007) · Journal of the American Chemical Society · doi:10.1021/ja067785e · Cited by 403
Blocking of the PD‐1/PD‐L1 Interaction by a D‐Peptide Antagonist for Cancer Immunotherapy
Chang, H., Liu, B., Qi, Y., Zhou, Y., Chen, Y., Pan, K., Li, W., Zhou, X., Ma, W., Fu, C., et al. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201506225 · Cited by 397
Fang, J., Zhang, B., Yao, Q., Yang, Y., Xie, J., & Yan, N. (2016) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2016.05.003 · Cited by 351
Self-citationPark, G. Y., Wilson, J. J., Song, Y., & Lippard, S. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207670109 · Cited by 330
Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies
Ho, G. Y., Woodward, N., & Coward, J. I. G. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.03.014 · Cited by 325
Wang, Y., Cai, R., & Chen, C. (2019) · Accounts of Chemical Research · doi:10.1021/acs.accounts.9b00126 · Cited by 303
Cao, M., Cai, R., Zhao, L., Guo, M., Wang, L., Wang, Y., Zhang, L., Wang, X., Yao, H., Xie, C., et al. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00856-w · Cited by 271
Functionalization of Platinum Complexes for Biomedical Applications
Wang, X., Wang, X., & Guo, Z. (2015) · Accounts of Chemical Research · doi:10.1021/acs.accounts.5b00203 · Cited by 268
Drug Delivery Strategies for Platinum-Based Chemotherapy
Browning, R. J., Reardon, P. J. T., Parhizkar, M., Pedley, R. B., Edirisinghe, M., Knowles, J. C., & Stride, E. (2017) · ACS Nano · doi:10.1021/acsnano.7b04092 · Cited by 247
Peptide–Drug Conjugates with Different Linkers for Cancer Therapy
Alas, M., Saghaeidehkordi, A., & Kaur, K. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01530 · Cited by 246
Karges, J., Yempala, T., Tharaud, M., Gibson, D., & Gasser, G. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201916400 · Cited by 232
Platinum Nanoparticles to Enable Electrodynamic Therapy for Effective Cancer Treatment
Gu, T., Wang, Y., Lu, Y., Cheng, L., Feng, L., Zhang, H., Li, X., Han, G., & Liu, Z. (2019) · Advanced Materials · doi:10.1002/adma.201806803 · Cited by 225
Yimit, A., Adebali, O., Sancar, A., & Jiang, Y. (2019) · Nature Communications · doi:10.1038/s41467-019-08290-2 · Cited by 222
Nanoparticle formulations of cisplatin for cancer therapy
Duan, X., He, C., Kron, S. J., & Lin, W. (2016) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1390 · Cited by 216
Cancer‐Targeted Nanotheranostics: Recent Advances and Perspectives
Ma, Y., Huang, J., Song, S., Chen, H., & Zhang, Z. (2016) · Small · doi:10.1002/smll.201600635 · Cited by 216
Ling, X., Chen, X., Riddell, I. A., Tao, W., Wang, J., Hollett, G., Lippard, S. J., Farokhzad, O. C., Shi, J., & Wu, J. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b01924 · Cited by 209
Yang, Y., Liu, X., Ma, W., Xu, Q., Chen, G., Wang, Y., Xiao, H., Li, N., Liang, X.-J., Yu, M., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2020.120456 · Cited by 209
Casini, A., & Reedijk, J. (2012) · Chemical Science · doi:10.1039/c2sc20627g · Cited by 196
Targeting the Thioredoxin System as a Strategy for Cancer Therapy: Miniperspective
Bian, M., Fan, R., Zhao, S., & Liu, W. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01595 · Cited by 196
Wang, K., Zhu, C., He, Y., Zhang, Z., Zhou, W., Muhammad, N., Guo, Y., Wang, X., & Guo, Z. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201900387 · Cited by 171
Yang, W., Guo, W., Chang, J. K., & Zhang, B. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb02308h · Cited by 165
Peptide Blocking of PD-1/PD-L1 Interaction for Cancer Immunotherapy
Li, C., Zhang, N., Zhou, J., Ding, C., Jin, Y., Cui, X., Pu, K., & Zhu, Y. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0035 · Cited by 161
Peptide-based nanoprobes for molecular imaging and disease diagnostics
Zhang, P., Cui, Y., Anderson, C. F., Zhang, C., Li, Y., Wang, R., & Cui, H. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00793k · Cited by 160
Self-citationMechanisms of platinum drug resistance
Ohmichi, M., Hayakawa, J., Tasaka, K., Kurachi, H., & Murata, Y. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.01.002 · Cited by 159
Platinum( iv ) prodrugs with long lipid chains for drug delivery and overcoming cisplatin resistance
Chen, Q., Yang, Y., Lin, X., Ma, W., Chen, G., Li, W., Wang, X., & Yu, Z. (2018) · Chemical Communications · doi:10.1039/c8cc02791a · Cited by 156
In vitro studies on the mechanisms of oxaliplatin resistance
Hector, S., Bolanowska-Higdon, W., Zdanowicz, J., Hitt, S., & Pendyala, L. (2001) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800100363 · Cited by 154
Kasherman, Y., Stürup, S., & Gibson, D. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900138u · Cited by 152
Mass spectrometry for the assessment of the occurrence and biological consequences of DNA adducts
Liu, S., & Wang, Y. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00316d · Cited by 150
Xu, Y., Han, X., Li, Y., Min, H., Zhao, X., Zhang, Y., Qi, Y., Shi, J. Y., Qi, S., Bao, Y., et al. (2019) · ACS Nano · doi:10.1021/acsnano.9b07032 · Cited by 149
Third row transition metals for the treatment of cancer
Johnstone, T. C., Suntharalingam, K., & Lippard, S. J. (2015) · Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rsta.2014.0185 · Cited by 143
Biotin-tagged platinum( iv ) complexes as targeted cytostatic agents against breast cancer cells
Nafees, M., Nasreen, S., Zhu, C., Luo, C., Guo, Z., & Wang, X. (2017) · Chemical Communications · doi:10.1039/c7cc05311h · Cited by 139
Wagstaff, A. J., Brown, S. D., Holden, M., Craig, G. E., Plumb, J. A., Brown, R. E., Schreiter, N., Chrzanowski, W., & Wheate, N. (2012) · Inorganica Chimica Acta · doi:10.1016/j.ica.2012.05.012 · Cited by 136
Yang, Y., Adebalı, O., Wu, G., Selby, C. P., Chiou, Y., Rashid, N. U., Hu, J., Hogenesch, J. B., & Sancar, A. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1804493115 · Cited by 134
Zhou, F., Feng, B., Yu, H., Wang, D., Wang, T., Liu, J., Meng, Q., Wang, S., Zhang, P., Zhang, Z., et al. (2016) · Theranostics · doi:10.7150/thno.14556 · Cited by 128
Gao, F., Cai, P., Yang, W., Xue, J., Gao, L., Liu, R., Wang, Y., Zhao, Y., He, X. B., Zhao, L., et al. (2015) · ACS Nano · doi:10.1021/nn507130k · Cited by 123
Self-citationXia, H., Li, F., Hu, X., Park, W., Wang, S., Jang, Y. J., Du, Y., Baik, S., Cho, S., Kang, T., et al. (2016) · ACS Central Science · doi:10.1021/acscentsci.6b00197 · Cited by 122
Hu, C., Yang, X., Liu, R., Ruan, S., Zhou, Y., Xiao, W., Yu, W., Yang, C., & Gao, H. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b04847 · Cited by 117
Targeted Gold Nanocluster‐Enhanced Radiotherapy of Prostate Cancer
Luo, D., Wang, X., Zeng, S., Ramamurthy, G., Burda, C., & Basilion, J. P. (2019) · Small · doi:10.1002/smll.201900968 · Cited by 117
Gandioso, A., Shaili, E., Massaguer, A., Artigas, G., González-Cantó, A., Woods, J. A., Sadler, P. J., & Marchán, V. (2015) · Chemical Communications · doi:10.1039/c5cc03180j · Cited by 116
Quantification of Nanomaterial/Nanomedicine Trafficking in Vivo
Wang, L., Yan, L., Liu, J., Chen, C., & Zhao, Y. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b04765 · Cited by 109
Unexpected therapeutic effects of cisplatin
Raudenská, M., Balvan, J., Fojtů, M., Gumulec, J., & Masařík, M. (2019) · Metallomics · doi:10.1039/c9mt00049f · Cited by 109
Progress in the Development of Preventative Drugs for Cisplatin-Induced Hearing Loss
Hazlitt, R. A., Min, J., & Zuo, J. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01653 · Cited by 108
Legin, A. A., Schintlmeister, A., Jakupec, M. A., Galanski, M. S., Lichtscheidl, I., Wagner, M., & Keppler, B. K. (2014) · Chemical Science · doi:10.1039/c3sc53426j · Cited by 105
Porous Pt nanoparticles loaded with doxorubicin to enable synergistic Chemo-/Electrodynamic Therapy
Chen, T., Gu, T., Cheng, L., Li, X., Han, G., & Liu, Z. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120202 · Cited by 105
Xiao, H., Noble, G. T., Stefanick, J. F., Qi, R., Kiziltepe, T., Jing, X., & Bilgiçer, B. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.10.020 · Cited by 104
Zhang, J., Zhao, B., Chen, S., Wang, Y., Zhang, Y., Wang, Y., Wei, D., Zhang, L., Rong, G., Weng, Y., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c03781 · Cited by 101
An artificial metalloenzyme for catalytic cancer-specific DNA cleavage and operando imaging
Gao, L., Zhang, Y., Zhao, L., Niu, W., Tang, Y., Gao, F., Cai, P., Yuan, Q., Wang, X., Jiang, H., et al. (2020) · Science Advances · doi:10.1126/sciadv.abb1421 · Cited by 100
Self-citationAu Clusters Treat Rheumatoid Arthritis with Uniquely Reversing Cartilage/Bone Destruction
Gao, F., Yuan, Q., Cai, P., Gao, L., Zhao, L., Liu, M., Yao, Y., Chai, Z., & Gao, X. (2019) · Advanced Science · doi:10.1002/advs.201801671 · Cited by 94
Self-citationA Peptide-Coated Gold Nanocluster Exhibits Unique Behavior in Protein Activity Inhibition
An, D., Su, J., Weber, J. K., Gao, X., Zhou, R., & Li, J. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b00888 · Cited by 91
Self-citationFe3O4@Pt nanoparticles to enable combinational electrodynamic/chemodynamic therapy
Chen, T., Chu, Q., Li, M., Han, G., & Li, X. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00957-7 · Cited by 86
Peptide-templated noble metal catalysts: syntheses and applications
Wang, W., Anderson, C. F., Wang, Z., Wu, W., Cui, H., & Liu, C. (2017) · Chemical Science · doi:10.1039/c7sc00069c · Cited by 84
Platinum drugs: from Pt(II) compounds, Pt(IV) prodrugs, to Pt nanocrystals/nanoclusters
Hu, X., Li, F., Noor, N., & Ling, D. (2017) · 中国科学通报：英文版 · doi:10.1016/j.scib.2017.03.008 · Cited by 82
Multifunctional platinum‐based nanoparticles for biomedical applications
Cheng, Q., & Liu, Y. (2016) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1410 · Cited by 80
Ultrasmall Superparamagnetic Iron Oxide Nanoparticle for T 2 -Weighted Magnetic Resonance Imaging
Wang, Y., Xu, C., Chang, Y., Zhao, L., Zhang, K., Zhao, Y., Gao, F., & Gao, X. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b10030 · Cited by 78
Self-citationA Triangular Platinum(II) Multinuclear Complex with Cytotoxicity Towards Breast Cancer Stem Cells
Eskandari, A., Kundu, A., Ghosh, S., & Suntharalingam, K. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201905389 · Cited by 77
Corte‐Rodríguez, M., Espina, M., Sierra, L. M., Blanco, E., Ames, T. D., Montes‐Bayón, M., & Sanz‐Medel, A. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.08.112 · Cited by 70
Wang, Y., Xia, K., Wang, L., Wu, M., Sang, X., Wan, K., Zhang, X., Liu, X., & Wei, G. (2021) · Small · doi:10.1002/smll.202005578 · Cited by 70
Gu, T., Chen, T., Cheng, L., Li, X., Han, G., & Liu, Z. (2020) · Nano Research · doi:10.1007/s12274-020-2838-1 · Cited by 65
Tian, F., Chen, G., Yi, P., Zhang, J., Li, A., Zhang, J., Zheng, L., Deng, Z., Shi, Q., Peng, R., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.052 · Cited by 63
Shiny, P. J., Mukherjee, A., & Chandrasekaran, N. (2016) · RSC Advances · doi:10.1039/c5ra27185a · Cited by 62
Facile Approach To Observe and Quantify the αIIbβ3 Integrin on a Single-Cell
Zhai, J., Wang, Y., Xu, C., Zheng, L., Wang, M., Feng, W., Gao, L., Zhao, L., Liu, R., Gao, F., et al. (2015) · Analytical Chemistry · doi:10.1021/ac504639u · Cited by 61
Self-citationHu, D., Yang, C., Lok, C., Xing, F., Lee, P., Fung, Y. M. E., Jiang, H., & Che, C. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201904131 · Cited by 59
Luo, K., Guo, W., Yu, Y., Xu, S., Zhou, M., Xiang, K., Niu, K., Zhu, X., Zhu, G., An, Z., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.06.005 · Cited by 56
Turiel-Fernández, D., Gutierrez-Romero, L., Corte‐Rodríguez, M., Bettmer, J., & Montes‐Bayón, M. (2021) · Analytica Chimica Acta · doi:10.1016/j.aca.2021.338356 · Cited by 55
Chien, C., Yan, J., Chiu, W., Wu, T., Liu, C., & Lin, S. (2013) · Advanced Materials · doi:10.1002/adma.201302363 · Cited by 53
Voulgari, E., Bakandritsos, A., Galtsidis, S., Zoumpourlis, V., Burke, B. P., Clemente, G. S., Cawthorne, C., Archibald, S. J., Tuček, J., Zbořil, R., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.10.021 · Cited by 51
15 Years of Small: Research Trends in Nanosafety
Zhu, S., Li, L., Gu, Z., Chen, C., & Zhao, Y. (2020) · Small · doi:10.1002/smll.202000980 · Cited by 50
Turning On/Off the Anti-Tumor Effect of the Au Cluster via Atomically Controlling Its Molecular Size
Zhai, J., Jia, Y., Zhao, L., Yuan, Q., Gao, F., Zhang, X., Cai, P., Gao, L., Guo, J., Yi, S., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b00027 · Cited by 48
Self-citationZhang, X., He, C., Liu, X., Chen, Y., Zhao, P., Chen, C., Yan, R., Li, M., Fan, T., Altine, B., et al. (2020) · Theranostics · doi:10.7150/thno.41077 · Cited by 47
Yuan, Q., Gao, F., Yao, Y., Cai, P., Zhang, X., Yuan, J., Hou, K., Gao, L., Ren, X., & Gao, X. (2019) · Theranostics · doi:10.7150/thno.31893 · Cited by 46
Self-citationPeptide and protein modified metal clusters for cancer diagnostics
Su, D., Gao, L., Gao, F., Zhang, X., & Gao, X. (2020) · Chemical Science · doi:10.1039/d0sc01201g · Cited by 44
Self-citationWlodarczyk, M. T., Dragulska, S. A., Camacho‐Vanegas, O., Dottino, P., Jarzęcki, A. A., Martignetti, J. A., & Mieszawska, A. J. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00921 · Cited by 43
Recent Advances in the Synthesis, Properties, and Biological Applications of Platinum Nanoclusters
Huang, X., Li, Z., Yu, Z., Deng, X., & Xin, Y. (2019) · Journal of Nanomaterials · doi:10.1155/2019/6248725 · Cited by 37
Jiang, W., Wang, J., Yang, J., He, Z., Hou, Z., Luo, Y., Wang, L., Liu, J., Zhang, H., Zhao, Y., et al. (2017) · Nano Research · doi:10.1007/s12274-017-1925-4 · Cited by 35
Gold clusters prevent breast cancer bone metastasis by suppressing tumor-induced osteoclastogenesis
Zhang, Z., Yao, Y., Yuan, Q., Cao, L., Zhang, X., Yuan, J., Hou, K., Zhang, C., Du, Z., Gao, X., et al. (2020) · Theranostics · doi:10.7150/thno.42218 · Cited by 35
Self-citationDu, R., Xiao, H., Guo, G., Jiang, B., Yan, X., Li, W., Yang, X., Zhang, Y. X., Li, Y., & Jing, X. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.10.015 · Cited by 33
McKeon, A., Noonan, J., Devocelle, M. C., Murphy, B. M., & Griffith, D. M. (2017) · Chemical Communications · doi:10.1039/c7cc04764a · Cited by 33
Nie, X., Zhang, J., Xu, Q., Liu, X., Li, Y., Wu, Y. F., & Chen, C. (2014) · Journal of Materials Chemistry B · doi:10.1039/c3tb21744b · Cited by 32
New steroidal 7-azaindole platinum(II) antitumor complexes
Zamora, A., Rodrı́guez, V., Cutillas, N., Yellol, G. S., Ferao, A. E., Samper, K. G., Capdevila, M., Palacios, Ò., & Ruiz, J. (2013) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2013.07.010 · Cited by 31
Karges, J., Yempala, T., Tharaud, M., Gibson, D., & Gasser, G. (2020) · Angewandte Chemie · doi:10.1002/ange.201916400 · Cited by 31
Zhang, X., Liu, R., Shu, Q., Yuan, Q., Xing, G., & Gao, X. (2018) · Small · doi:10.1002/smll.201703684 · Cited by 28
Self-citationRegulation of the high-affinity copper transporter (hCtr1) expression by cisplatin and heavy metals
Liang, Z. D., Long, Y., Chen, H. H. W., Savaraj, N., & Kuo, M. T. (2013) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-013-1051-z · Cited by 26
Wang, K., Zhu, C., He, Y., Zhang, Z., Zhou, W., Nafees, M., Guo, Y., Wang, X., & Guo, Z. (2019) · Angewandte Chemie · doi:10.1002/ange.201900387 · Cited by 25
Cormier, L. E., Keeling, J. K., Rollins, J. D., Black, C. A., Collins, K., Arnold, N., Vance, D. E., & Ndinguri, M. W. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00610 · Cited by 22
Carboplatin-loaded SMNDs to reduce GSH-mediated platinum resistance for prostate cancer therapy
Liang, S., Han, L., Mu, W., Jiang, D., Hou, T., Yin, X., Pang, X., Yang, R., Liu, Y., & Zhang, N. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb01721b · Cited by 21
Facilitating the Cellular Accumulation of Pt-Based Chemotherapeutic Drugs
Lambert, I. H., & Sørensen, B. H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082249 · Cited by 19
A Triangular Platinum(II) Multinuclear Complex with Cytotoxicity Towards Breast Cancer Stem Cells
Eskandari, A., Kundu, A., Ghosh, S., & Suntharalingam, K. (2019) · Angewandte Chemie · doi:10.1002/ange.201905389 · Cited by 18
Zhai, J., Zhao, L., Zheng, L., Gao, F., Gao, L., Liu, R., Wang, Y., & Gao, X. (2017) · ACS Omega · doi:10.1021/acsomega.6b00390 · Cited by 17
Self-citationIs GSH Chelated Pt Molecule Inactive in Anti‐Cancer Treatment? A Case Study of Pt6GS4
Zhang, C., Gao, L., Yuan, Q., Zhao, L., Niu, W., Cai, P., Li, J., Han, X., He, Z., Gao, F., et al. (2020) · Small · doi:10.1002/smll.202002044 · Cited by 16
Self-citationXu, Y.-Y., Jiang, N., & Yu, H. (2010) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2010.508081 · Cited by 12
Cited by
Drug-microbiota interactions: an emerging priority for precision medicine
Zhao, Q., Chen, Y., Huang, W., Zhou, H., & Zhang, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01619-w · Cited by 268
Hu, D., Li, Y., Li, R., Wang, M., Zhou, K., He, C., Wei, Q., & Qian, Z. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.10.015 · Cited by 153
Injectable hydrogels as emerging drug-delivery platforms for tumor therapy
Cheng, Y., Zhang, H., Wei, H., & Yu, C.-Y. (2024) · Biomaterials Science · doi:10.1039/d3bm01840g · Cited by 65
Current Status of Research on Losartan in Tumour Therapy
Wang, H., Yuan, S., & Wang, H. (2026) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70985 · Cited by 11
Metadata
- Authors
- Zhang, C., Xu, C., Gao, X., & Yao, Q.
- Venue
- Theranostics
- Publisher
- Ivyspring International Publisher
- Published
- 2022
- Volume
- 12
- Issue
- 5
- Pages
- 2115-2132
- ISSN
- 1838-7640 (ISSN-L)
- OpenAlex
- W4210853074
- Cited by
- 1,018
- References
- 113
- FWCI
- 69.33
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
